Previously, the task force only recommended Truvada and its generics for use as pre-exposure prophylaxis to prevent HIV. Now, the expert panel is also backing the pill Descovy and the injectable medication Apretude as additional options.
The recommendation means private insurers will be required to cover the drugs without co-pays or deductibles and comes as the White House aims to preserve coverage of preventive services under the ACA, according to The New York Times. Last year, a federal judge ruled the mandate unconstitutional, arguing that requiring private insurers to cover PREP, in particular, violated employers’ religious rights.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
